• 2013
• Working Paper

Inequality and Decision Making: Imagining a New Line of Inquiry

By: David Moss, Anant Thaker and Howard Rudnick

The substantial increase in inequality in the United States over the past three decades has provoked considerable debate, with some analysts characterizing rising inequality as among the greatest threats facing the nation and others dismissing it as little more than a... View Details

Keywords: Equality and Inequality; Income; Decision Making; Government and Politics; Economics; United States

Citation

SSRN

Read Now

Related

Moss, David, Anant Thaker, and Howard Rudnick. "Inequality and Decision Making: Imagining a New Line of Inquiry." Harvard Business School Working Paper, No. 13-099, June 2013.

• September 2008 (Revised June 2013)
• Case

Odyssey Healthcare

By: Robert F. Higgins, Virginia Fuller and Umer Raffat

In January 2001, Dick Burnham, CEO of Odyssey Healthcare, and Odyssey's Board of Directors were considering selling the hospice care company to a larger provider or making an initial public offering (IPO). With 38 hospice locations in 21 states, Odyssey had been... View Details

Keywords: Liquidity; Venture Creation/development; Hospice; Venture Capital; Financial Liquidity; Business Exit or Shutdown; Business Growth and Maturation; Business Plan; Entrepreneurship; Health Industry; United States

Citation

Educators

Purchase

Related

Higgins, Robert F., Virginia Fuller, and Umer Raffat. "Odyssey Healthcare." Harvard Business School Case 809-052, September 2008. (Revised June 2013.)

• 25 Apr 2018
• Blog Post

Policy, Practice, Leadership & Impact: Making a Difference with the HBS/HKS Joint Degree

Swaziland to work with the Clinton Health Access Initiative (CHAI) until two years later she was admitted into the HBS/HKS Joint Degree Program. We caught up with Nanako to learn more about her experience with the HBS/HKS joint degree... View Details

Keywords: Nonprofit / Government

• February 2022 (Revised November 2022)
• Case

Nuritas

By: Mitchell Weiss, Satish Tadikonda, Vincent Dessain and Emer Moloney

Nora Khaldi had built a technology “to unlock the power of nature” in the service of extending human lifespan and improving health, and now in April 2020 was debating telling her Board of Directors she wanted to put on ice some of her discoveries. Nuritas, the company... View Details

Keywords: Cash Burn; Cash Flow Analysis; Pharmaceutical Companies; Founder; Artificial Intelligence; AI; Entrepreneurship; Health Testing and Trials; Health Care and Treatment; Decision Making; Market Entry and Exit; AI and Machine Learning; Pharmaceutical Industry

Citation

Educators

Purchase

Related

Weiss, Mitchell, Satish Tadikonda, Vincent Dessain, and Emer Moloney. "Nuritas." Harvard Business School Case 822-080, February 2022. (Revised November 2022.)

• 01 Jan 2024
• Blog Post

Answers to Your Top Questions about Financial Aid at HBS

Students can also work with the Financial Aid team to get help securing the loans required to cover the full cost of the MBA. With this support in mind, please visit the Cost of Attendance page to view an... View Details

• 24 Feb 2021
• News

How to Negotiate and Avoid Costly Medical Bills

• Article

Operational Efficiency and Effective Management in the Catheterization Laboratory

By: Grant W. Reed, Michael L. Tushman and Samir R. Kapadia

Operational efficiency is a core business principle in which organizations strive to deliver high-quality goods or services in a cost-effective manner. This concept has become increasingly relevant to cardiac catheterization laboratories, as insurers move away from... View Details

Keywords: Cath Lab; Catheterization Laboratory; Health Care and Treatment; Performance Efficiency; Management; Performance Productivity; Cost Management; Health Industry

Citation

Find at Harvard

Read Now

Related

Reed, Grant W., Michael L. Tushman, and Samir R. Kapadia. "Operational Efficiency and Effective Management in the Catheterization Laboratory." Journal of the American College of Cardiology 72, no. 20 (November 20, 2018): 2507–2517.

• 12 Jun 2012
• First Look

First Look: June 12

seek and how firms could deliver it. The result can be new revenue, increased customer satisfaction and loyalty, positive word of mouth, and cost savings. The multiyear process to price the 8 million tickets to the upcoming London 2012... View Details

Keywords: Sean Silverthorne

• 19 Apr 2018
• Blog Post

Policy, Practice, Leadership & Impact: Making a Difference with the HBS/HKS Joint Degree

City and then moved to Swaziland to work with the Clinton Health Access Inititiative (CHAI) until two years later she was admitted into the HBS/HKS Joint Degree Program. We caught up with Nanako to learn more about her experience with the... View Details

• May 2021
• Article

Preparing for a Pandemic: Accelerating Vaccine Availability

By: Amrita Ahuja, Susan Athey, Arthur Baker, Eric Budish, Juan Camilo Castillo, Rachel Glennerster, Scott Duke Kominers, Michael Kremer, Jean Lee, Canice Prendergast, Christopher M. Snyder, Alex Tabarrok, Brandon Joel Tan and Witold Wiecek

Vaccinating the world’s population quickly in a pandemic has enormous health and economic benefits. We analyze the problem faced by governments in determining the scale and structure of procurement for vaccines. We analyze alternative approaches to procurement, arguing... View Details

Keywords: Vaccines; Procurement; Health Pandemics; Health Care and Treatment; Acquisition; Cooperation

Citation

Find at Harvard

Read Now

Related

Ahuja, Amrita, Susan Athey, Arthur Baker, Eric Budish, Juan Camilo Castillo, Rachel Glennerster, Scott Duke Kominers, Michael Kremer, Jean Lee, Canice Prendergast, Christopher M. Snyder, Alex Tabarrok, Brandon Joel Tan, and Witold Wiecek. "Preparing for a Pandemic: Accelerating Vaccine Availability." AEA Papers and Proceedings 111 (May 2021): 331–335.

• August 2012 (Revised August 2024)
• Case

ABC Pharmaceuticals

By: Regina E. Herzlinger and Erik R. Sparks

This case asks students to price a new drug that is in Stage II of its clinical trials. It contains detailed estimates of the time required and costs for all the steps needed to commercialize a drug in the U.S. Students will learn virtually all the steps required to... View Details

Keywords: Drug Development; Price; Product; Product Launch; Health Industry; Health Industry; Health Industry

Citation

Educators

Purchase

Related

Herzlinger, Regina E., and Erik R. Sparks. "ABC Pharmaceuticals." Harvard Business School Case 313-041, August 2012. (Revised August 2024.)

• March 1999
• Case

Merck & Co., Inc.: Corporate Strategy, Organization and Culture (A)

By: Michael Beer and Perry Fagan

In the early 1990s, Merck faced a series of challenges because of significant changes in its competitive and regulatory environment (e.g., growth in power of pharmaceutical buyers like managed care organizations led to price pressures and President Clinton's review of... View Details

Keywords: Organizational Change and Adaptation; Business or Company Management; Organizational Culture; Problems and Challenges; Management Practices and Processes; Competitive Strategy; Management Teams; Health Care and Treatment; Governing Rules, Regulations, and Reforms; Situation or Environment; Alignment; Pharmaceutical Industry; United States

Citation

Educators

Purchase

Related

Beer, Michael, and Perry Fagan. "Merck & Co., Inc.: Corporate Strategy, Organization and Culture (A)." Harvard Business School Case 499-054, March 1999.

• Web

Technology & Operations Management - Doctoral

Ayelet Israeli Entrepreneurship Thomas R. Eisenmann Kyle R. Myers Maria P. Roche Sara McKinley Torti Environment Michael W. Toffel Health care quality Robert S. Huckman Information technology Iavor I.... View Details

• Web

Hiring Organizations

Dhabi Investment Council Accion Venture Labs Accompany Health Acontor Innovations Private Limited Actis Active Surfaces AdaptHealth Adenia Partners Adept - adept.ai Admaius Capital Partners Adobe Advent International Aid Pioneers AIRS... View Details